Senior insider sale
Group VP & Rilonacept GM at KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC — senior position signals high conviction
$194.5K
4.07K shares
What this filing means
MOAT ROSS plans to sell 4.07K shares of KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC valued at approximately $194.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/9/2026ACC: 0001921094-26-000387
Officer· Group VP & Rilonacept GM
Since Apr 2021
4.07K
Shares to sell
$194.5K
Approx. market value
1.70K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Lapse
Equity Compensation
4/7/2026
1.70KTotal acquired1.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/7/2026 | Restricted Stock Lapse Equity Compensation | 1.70K | — |
| Total | 1.70K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.37K
Market value
$115.0K
4/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.70K
Market value
$79.5K
4/9/2026
Total
Units
4.07K
Value
$194.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/6/2026 | 2.37K | $115.0K | — | Completed |
| Planned — Approximate Date | ||||
4/9/2026 | 1.70K | $79.5K | NASDAQ | Planned |
| Total | 4.07K | $194.5K | ||